Ilimaquinone is primarily studied for its anti-inflammatory and anticancer properties. It has shown potential in inhibiting the activation of nuclear factor-kappa B (NF-κB), a key regulator of inflammation and immune response, making it a candidate for development in treating chronic inflammatory diseases. In cancer research, ilimaquinone exhibits cytotoxic effects against certain tumor cell lines by inducing apoptosis and disrupting cellular signaling pathways. Additionally, it has been investigated for its antiviral activity, particularly against enveloped viruses, due to its ability to interfere with vesicular trafficking in host cells. Its unique mechanism of action continues to make it a valuable tool in cell biology studies, especially in understanding Golgi apparatus disassembly and intracellular transport.